Yawei Zheng
Overview
Explore the profile of Yawei Zheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cao J, Zheng Y, Li R, Feng D, Ni X, Gao H, et al.
Am J Hematol
. 2025 Feb;
PMID: 39950584
No abstract available.
2.
Fan Y, Jialiken D, Zheng Z, Zhang W, Zhang S, Zheng Y, et al.
J Ethnopharmacol
. 2024 Oct;
337(Pt 3):118896.
PMID: 39393558
Ethnopharmacological Relevance: Qianyang Yuyin granules (QYYY) have been used clinically to treat hypertension for over two decades. Previous clinical trials have shown that QYYY can improve vascular elastic function in...
3.
Sun H, Wu L, Zhao X, Huo Y, Dong P, Pang A, et al.
Front Immunol
. 2024 Sep;
15:1433091.
PMID: 39328417
Acute graft-versus-host disease (aGVHD) is a major complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and contributes to high morbidity and mortality. However, our current understanding of the development and...
4.
Zheng Y, Fang Y, Li L, Wang H, Zhang S, Zhu Y, et al.
Phytother Res
. 2024 Sep;
38(11):5376-5388.
PMID: 39243217
Quercetin has shown potential antihypertensive-like activities in several studies. The present study aimed to test the effect of quercetin supplementation on kidney damage and long-term prognosis in hypertensive patients. The...
5.
Gao H, Zhang Z, Wang J, Jia Y, Zheng Y, Pei X, et al.
Exp Hematol Oncol
. 2024 Aug;
13(1):88.
PMID: 39182130
The optimal timing and type of hematopoietic stem cell transplantation (HSCT) for treating peripheral T-cell lymphoma (PTCL) remain controversial. This retrospective real-world study investigated the application pattern and outcomes of...
6.
Li N, Hong R, Zhou W, Zhong J, Kan M, Zheng Y, et al.
Rev Cardiovasc Med
. 2024 Jul;
23(7):244.
PMID: 39076900
Introduction: For chronic kidney disease (CKD) patients with or without cardiovascular diseases, the associations between leisure-time physical activity intensity (LTPA) and daily exercise time with mortality risk remain unclear. Method:...
7.
Cao J, Pan P, Feng D, Wang M, Zheng Y, Yang N, et al.
Clin Microbiol Infect
. 2024 Jul;
30(12):1585-1591.
PMID: 39067514
Objectives: To evaluate posaconazole (POS) gastro-resistant tablets for preventing invasive fungal disease (IFD) in haematopoietic stem cell transplantation (HSCT) patients and analyse POS plasma concentrations. Methods: A single-arm trial was...
8.
Zheng Y, Fang Y, Luo Y, Fan Y, Fang Z
J Ethnopharmacol
. 2024 Jul;
335:118610.
PMID: 39047880
Ethnopharmacological Relevance: Clinical studies have found that Qianyang Yuyin granule (QYYYG), a kind of oral Chinese patent medicine, had definite clinical effect for hypertensive myocardial remodeling. However, the potential mechanism...
9.
Qian L, Xu Z, Chen Y, Gao Z, Luo T, Wu L, et al.
Heliyon
. 2024 Jul;
10(12):e33369.
PMID: 39022064
Objective: To explore the effects and possible mechanisms of the drug pair Cornus officinalis and Radix achyranthis bidentatae (SYR-NX) on improving hypertensive kidney damage. Method: SYR-NX, a formulation of Cornus...
10.
Guo W, Zhang H, Wang M, Zheng Y, Cao Y, Zhang X, et al.
Ann Hematol
. 2024 Jul;
103(8):2827-2836.
PMID: 38969929
Wilms tumor 1 (WT1) gene mutations are infrequent in myelodysplastic syndrome (MDS), but MDS with WT1 mutations (WT1) is considered high risk for acute myeloid leukemia (AML) transformation. The influence...